Given the high penetrance and rapid development of MMs in Ptenf/f;Tp53f/f mice inoculated i.p., and the frequent involvement of p14ARF/p53 and PI3K/PTEN/AKT pathways in human MM, this GEM model holds promise for preclinical work. Here, AKT1 is linked to Miyoshi myopathy.